GenEp is a pre-clinical biotechnology company focused on developing novel therapeutic solutions based on proprietary genetic sequencing technologies. The company aims to address unmet medical needs by leveraging its intellectual property to advance drug discovery and development processes.
Funding
$9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Drug discovery and development is often hindered by a limited understanding of the genetic factors influencing disease. Traditional therapeutic approaches may not effectively address the underlying genetic complexities of various conditions.
Solution
GenEp is a pre-clinical biotechnology company that develops therapeutic solutions by applying proprietary genetic sequencing technologies to drug discovery. The company leverages its intellectual property to identify and target specific genetic markers associated with disease. By focusing on the genetic underpinnings of disease, GenEp aims to create more effective and personalized therapeutic interventions.
Target Audience
The primary target audience includes pharmaceutical companies and research institutions seeking novel therapeutic targets and advanced drug discovery platforms.
Features
- Proprietary genetic sequencing technologies for identifying disease-related genetic markers
- Targeted drug discovery and development processes
- Focus on personalized therapeutic interventions